Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Search & Filter

Enter one or more words in to the search box and press Enter.
With each additional filter selection requires the articles to have each of the categories selected.

  • Filter by Section

  • Filter by Author

First guideline for management of Sjorgen’s syndrome in adults published

October 6, 2022
admin
The first UK guideline on the care of adults with Primary Sjögren's Syndrome has been published by the British Society of Rheumatology. The guidelines are accredited by the National Institute for Health and Care Excellence (NICE).

New deal for breast cancer drug offers hope to patients

October 7, 2022
admin
A new deal on the breast cancer drug Kadcyla (trastuzumab emtansine) means that it can now be recommended for routine funding on the NHS.

More cuts needed to adult social care budgets

October 6, 2022
admin
Despite extra funding and plans to spend more on adult social care budgets, more cuts need to be made in the service, according to a survey of 151 adult social services directors in England.

NHS patients in England are getting early access to new drugs for lung cancer and sarcoma

October 6, 2022
admin
NHS patients in England are getting early access to new drugs for lung cancer and sarcoma, after NICE says they should be available on the Cancer Drugs Fund (CDF).

Syncope: a benign condition? (Part 2)

October 6, 2022
admin
Syncope is a sudden, but brief loss of consciousness caused by inadequate perfusion to the brain. It is typically characterised by a loss of postural tone, and a spontaneous return to baseline neurological function and usually requiring no resuscitative efforts.

Screening for atrial fibrillation: a societal imperative (Part 2)

October 6, 2022
admin
Atrial fibrillation (AF) affects more than 2.4% of the population. AF-related stroke is a major cause of physical and cognitive disability, and mortality. This article summarises the current recommendations and suggested strategies for AF screening.

Type 1 diabetes and older people

October 6, 2022
admin
More than one in five cases of Type 1 diabetes are diagnosed in people aged over 40, according to new figures announced recently at Diabetes UK's annual Diabetes Professional Conference.

Social networking used to recruit patients with type 1 diabetes

October 6, 2022
admin
Diabetes researchers are using social networking to help them recruit and retain people who have just been diagnosed with type 1 diabetes, according to a new study.

Local hospitals improve diabetes referrals and patient care

October 6, 2022
admin
A new system for making sure inpatients with diabetes get the care they need is improving diabetes healthcare at Sandwell and West Birmingham Hospitals NHS Trust, according to findings of a project presented at the Diabetes UK Professional Conference.

Diabetes-related foot attack on the increase

October 6, 2022
admin
There are currently an estimated one million people with diabetes who are at high or increased risk of a diabetes-related foot attack and too many of these people do not understand that delays to treatment could result in amputation, says Diabetes UK recently at their Professional Conference.

NICE approves new treatment for Crohn’s disease

October 6, 2022
admin
NICE has recommended ustekinumab (Stelara) as an option for treating moderate to severe Crohn's disease in adults who have had little or no response, or an intolerance to existing therapies.

Overweight boys who return to normal weight before adulthood remove increased diabetes risk

October 6, 2022
admin
Males who are overweight in childhood but achieve normal weight before adulthood have no increased risk of developing type 2 diabetes compared to men who were never overweight, research presented at the 77th American Diabetes Association congress found.

Medi launches new soft support range

October 6, 2022
admin
Medi has launched a new soft support range called E+motion, which aims to reflect the active lifestyle of people who see health as the highest priority.

Vitamin D and osteoporosis clinical benefits only in patients whose levels are reduced

October 6, 2022
admin
An international study of older adults has found that mass, untargeted provision of vitamin D supplements provides little clinical benefit to many when it comes to osteoporosis.

New type of treatment for Crohn’s disease is approved by NICE

October 6, 2022
admin
Ustekinumab (Stelara) has been recommended by NICE as an option for treating moderate to severe Crohn's disease in adults who have had little or no response, or an intolerance to existing therapies.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy